logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Pharmaceutical Perspectives Of Cancer Therapeutics 1st Edition Chikezie O Madu

  • SKU: BELL-4391250
Pharmaceutical Perspectives Of Cancer Therapeutics 1st Edition Chikezie O Madu
$ 31.00 $ 45.00 (-31%)

4.4

32 reviews

Pharmaceutical Perspectives Of Cancer Therapeutics 1st Edition Chikezie O Madu instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 9.65 MB
Pages: 694
Author: Chikezie O. Madu, Yi Lu (auth.), Yi Lu, Ram I. Mahato (eds.)
ISBN: 9781441901309, 9781441901316, 1441901302, 1441901310
Language: English
Year: 2009
Edition: 1

Product desciption

Pharmaceutical Perspectives Of Cancer Therapeutics 1st Edition Chikezie O Madu by Chikezie O. Madu, Yi Lu (auth.), Yi Lu, Ram I. Mahato (eds.) 9781441901309, 9781441901316, 1441901302, 1441901310 instant download after payment.

Pharmaceutical Perspectives of Cancer Therapeutics presents a comprehensive yet easy-to-follow review of the principles, current progress and state-of-the-art of cancer therapeutics. The complexity of cancer demands an integrated understanding from both cancer biology and pharmaceutical dosage forms and drug delivery in order to warrant a successful therapeutic regimen. This book combines and merges the knowledge from these two aspects. Internationally acclaimed experts with a multi-disciplinary background, including scientists and clinicians from both academia and industries have contributed to this book to bridge the following areas between basic research and clinical application, pharmaceutical drug development processes and regulatory issues, drug design and delivery, laboratory and translational experimentation, marketing and postmarketing surveillance.

Main features of the book:

  • Anticancer drug development and regulatory processes.
  • Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways.
  • Therapeutic approaches to employ monoclonal antibody and cancer vaccines.
  • Introduction of new concepts such as cancer stem cells and new technologies such as nanobiotechnology, RNA interference, microRNA, and cancer cell gene profiling.
  • Use of lipids, polymers and peptides for drug delivery and targeting to cancer cells or specific organs.
  • Utilization of bioimaging and HIF-1 knockout animal models in cancer study.
  • Clinical trials designs and principles

Related Products